Skip to main content

Table 1 Baseline patient characteristics

From: Home-based exercise and bone mineral density in peritoneal dialysis patients: a randomized pilot study

 

Intervention (n = 26)

Usual care (n = 27)

p

Male sex

20 (76.9)

21 (77.8)

1.00

Age (years)

66.19 ± 13.05

64.00 ± 12.95

0.542

PD vintage (years)

5.04 ± 3.10

5.07 ± 3.92

0.971

PD modality

  

0.428

 CAPD

15 (57.5)

16 (59.3)

 

 APD

9 (34.6)

7 (25.9)

 

 CAPD+APD

2 (7.7)

4 (14.8)

 

HD + PD combined therapy

16 (61.5)

13 (48.1)

0.412

BMI (kg/m2)

22.52 ± 3.94

23.30 ± 4.55

0.505

Kt/V PD

1.92 ± 0.47

1.85 ± 0.43

0.555

DM

8 (30.8)

9 (33.3)

1.00

Calcium (mg/dL)

8.51 ± 0.73

8.63 ± 0.77

0.562

Phosphates (mg/dL)

6.40 ± 2.01

5.73 ± 1.29

0.151

Albumin (g/dL)

3.44 ± 0.50

3.44 ± 0.32

0.995

Prealbumin (mg/dL)

39.22 ± 10.12

37.18 ± 8.44

0.432

Total protein (g/dL)

6.25 ± 0.78

6.43 ± 0.44

0.297

HbA1c (%)

5.74 ± 0.58

5.96 ± 0.70

0.226

Hemoglobin (g/dL)

11.44 ± 1.81

11.81 ± 1.53

0.423

Fasting blood sugar (mg/dL)

122.71 ± 46.81

116.68 ± 32.16

0.586

Cause of ESRD

 Diabetes

8 (30.8)

7 (25.9)

0.766

 Glomerulonephritis

8 (29.6)

8 (30.8)

1.00

 Nephrosclerosis

1 (3.8)

3 (11.1)

0.61

 IgA nephropathy

5 (19.2)

1 (3.7)

0.1

 Other diseases

4 (15.4)

8 (29.6)

0.327

Medication of CKD-MBD

 Phosphorus adsorbent

23 (88.5)

24 (88.9)

1.00

 Calcium receptor

14 (53.8)

10 (37.0)

0.275

 Active vitamin D3

11 (42.3)

16 (59.3)

0.276

  1. Values are given as mean ± standard deviation or n (%)
  2. Continuous variables, Student’s t-test; categorical data, chi-square test
  3. PD peritoneal dialysis, CAPD continuous ambulatory peritoneal dialysis, APD ambulatory peritoneal dialysis, HD hemodialysis, BMI body mass index, K dialyzer clearance of urea, t dialysis time, V volume of distribution of urea, DM diabetes mellitus, HbA1c glycated hemoglobin, ESRD end-stage renal disease, IgA immunoglobulin A, CKD-MBD chronic kidney disease-mineral and bone disorder